Schlieren, Switzerland
InSphero, founded in 2009 and headquartered in Switzerland, is a pioneering entity in the Biotechnology and Health Care industries. The company strives to modernize drug safety and efficacy testing with its slogan: "Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy testing | The Model of Excellence™".
Distinguished as the only 3D in vitro model company with a robust and scalable platform, InSphero enables researchers to optimize their drug discovery processes. Their cutting-edge spheroid-based models are designed to expedite the path to clinical trials for liver safety and disease, islet biology, as well as oncology and immunology research.
The most recent financial affirmation of InSphero's potential came in the form of a Venture Round investment on 31 March 2023, backed by ZEISS Ventures. This investment underscores the confidence in their mission to empower researchers and fuel a new era of drug discovery.
